• Explore /
  • Poster
  • / GRECO-2: A randomized, phase 2 study of stereotactic body radiation therapy (SBRT) in combination with GC4711 in the treatment of unresectable or borderline resectable nonmetastatic pancreatic cancer (PC).

GRECO-2: A randomized, phase 2 study of stereotactic body radiation therapy (SBRT) in combination with GC4711 in the treatment of unresectable or borderline resectable nonmetastatic pancreatic cancer (PC).

Abstract Video & Slides Poster

Authors

null

Sarah E. Hoffe

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Sarah E. Hoffe , Dae Won Kim , James Costello , Mokenge Peter Malafa , Todd Anthony Aguilera , Muhammad Shaalan Beg , Parag Parikh , Joseph M. Herman , Jon Holmlund , Kara Terry , Elizabeth Charlotte Moser

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

NCT04698915

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS4175)

DOI

10.1200/JCO.2021.39.15_suppl.TPS4175

Abstract #

TPS4175

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Todd Anthony Aguilera

First Author: Sarah E. Hoffe

First Author: Deirdre Jill Cohen

First Author: Junwei Wu